Health TrialsbyHealthPanel

Patients With Chemotherapy-Induced Thrombocytopenia

1

Review clinical trials related to Patients With Chemotherapy-Induced Thrombocytopenia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study to Evaluate the Efficacy and Safety of Hetrombopag Olamine Tablets Vs Placebo in Patients With Chemotherapy-Induced Thrombocytopenia (ExCIT)

The ExCIT study is being conducted to evaluate the efficacy, and safety of of Hetrombopag Olamine Tablets Vs Placebo in Patients with Chemotherapy-Induced Thrombocytopenia.

Participants needed: 150
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Jiangsu HengRui Medicine Co., Ltd.Updated: Oct 1, 2026Locations: 51
Eligibility criteria

Male or female, age ≥ 18 years at screening. [+8]

WHO Grade ≥ 2 bleeding within 14 days prior to screening. [+13]

Read more